puzzle picture
485: Quick Alignment Puzzle 482
Status: Closed


Name: 485: Quick Alignment Puzzle 482
Status: Closed
Created: 11/27/2011
Points: 60
Expired: 12/01/2011 - 03:30
Difficulty: Intermediate
Description: This is a quick repost of Puzzle 482: Advanced Alignment Puzzle, but this time we are providing you with secondary structure predictions that are posted in the puzzle comments and included in the starting structure as well. These predictions are from the SAM-T08 server (as requested in the previous puzzle comments: http://fold.it/portal/node/991105). Check out that page for more hints and make sure you beat Intro Puzzles 6-1 through 6-3 before playing this puzzle.
Categories: Overall, Prediction

Top Groups

2Trailer Trash10,29947
5L'Alliance Francophone10,22620

Top Evolvers

Top Soloists

1infjamc 33 19 Contenders10,62360
2BootsMcGraw 11 10 Contenders10,33559
3Junker 51 1401 10,29958
4mimi 51 1401 Contenders10,29256
5rsosborne 51 1401 foldeRNA10,28255

Need this puzzle? Log in to download.  


beta_helix's picture
User offline. Last seen 1 week 6 days ago. Offline
Joined: 05/09/2008
Groups: None
Please try to use these secondary structure predictions:

Here is the sequence logo predicted by the SAM server.

H = helix
E = sheet
C = loop (or coil)

The taller the letter at each position, the higher the probability of that specific secondary structure for that amino acid.

For example, the two Valines at residues 84 & 86 are highly predicted to be part of a sheet. However, the Valine at residue 9 is predicted to be either part of a loop or sheet.

User login
Download links:
  Windows    OSX    Linux  
(10.12 or later)

Are you new to Foldit? Click here.

Are you a student? Click here.

Are you an educator? Click here.
Social Media

Only search fold.it
Other Games: Mozak
Recommend Foldit
Top New Users

Developed by: UW Center for Game Science, UW Institute for Protein Design, Northeastern University, Vanderbilt University Meiler Lab, UC Davis
Supported by: DARPA, NSF, NIH, HHMI, Amazon, Microsoft, Adobe, Boehringer Ingelheim, RosettaCommons